Journal
ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE
Volume 10, Issue 3, Pages -Publisher
SAGE PUBLICATIONS INC
DOI: 10.1177/23259671221070857
Keywords
ASES; biceps tenodesis; clinically significant outcomes; minimum clinically important difference; timeline
Categories
Funding
- Arthrex
- Arthrosurface
- Athletico
- ConMed Linvatec
- DJO
- Miomed
- Mitek
- Ossur
- Smith Nephew
- Aesculap/B. Braun
- Regentis
Ask authors/readers for more resources
After isolated biceps tenodesis (BT), patients can expect to achieve clinically significant outcomes (CSOs) within 13 months postoperatively, with most patients achieving this between 5 and 8 months. Patients tend to take longer to achieve Patient Acceptable Symptom State (PASS) compared to achieving minimal clinically important difference (MCID) and substantial clinical benefit (SCB).
Background: Clinically significant outcomes (CSOs) connect patient-reported outcome measures data to patient-perceived benefit. Although investigators have established threshold values for various CSOs, the timeline to achieve these outcomes after isolated biceps tenodesis (BT) has yet to be defined. Purpose: To define the time-dependent nature of minimal clinically important difference (MCID), substantial clinical benefit (SCB), and Patient Acceptable Symptom State (PASS) achievement after isolated BT. Study Design: Case series; Level of evidence, 4. Methods: The American Shoulder and Elbow Surgeons score (ASES), the Single Assessment Numeric Evaluation, and the Constant-Murley score (CMS) were administered preoperatively and at 6 and 12 months postoperatively to patients undergoing isolated BT between 2014 and 2018 at our institution. Cumulative probabilities for achieving MCID, SCB, and PASS were calculated using Kaplan-Meier survival analysis. Weibull parametric regression evaluated the hazard ratios (HRs) of achieving earlier MCID, SCB, and PASS. Results: Overall cohort (N = 190) achievement rates ranged between 77.8% and 83.2% for MCID, between 42.2% and 80.2% for SCB, and between 59.7% and 62.9% for PASS. Median achievement time was 5.3 to 6.1 months for MCID, 5.9 to 6.4 months for SCB, and 6.07 to 6.1 months for PASS. Multivariate Weibull parametric regression identified older age, male sex, higher body mass index, preoperative thyroid disease, smoking history, and higher preoperative CMS as predictors of delayed CSO achievement (HR, 1.01-6.41), whereas normal tendon on arthroscopy, defined as absence of tenosynovitis or tendon tear on arthroscopy, predicted earlier CSO achievement (HR, 0.19-0.46). Location of tenodesis and worker compensation status did not significantly predict the time to achieve CSOs on multivariate analysis. Conclusion: After isolated BT, patients can expect to attain CSO by 13 months postoperatively, with most patients achieving this between 5 and 8 months. Patients tend to take longer to achieve PASS than MCID and SCB.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available